NCT05981924

Brief Summary

To explore the feasibility and effectiveness of Perioperative Music Therapy Plus Oxycodone in pain management after thoracic surgery, patients will be randomly assigned into two groups. The experimental group will receive perioperative music therapy and the control group will not. We will record and contrast the postoperative oxycodone usage to evaluate the effect of music therapy in relieving the pain. We will also use visual analogue scale, questionnaire and EEG to evaluate patients' anxiety and depression.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Aug 2023

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 31, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

August 1, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 8, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2024

Completed
Last Updated

July 17, 2024

Status Verified

July 1, 2024

Enrollment Period

6 months

First QC Date

July 31, 2023

Last Update Submit

July 15, 2024

Conditions

Keywords

Music TherapyAnxietyQuality of Life

Outcome Measures

Primary Outcomes (1)

  • The total dose of oxycodone within 48 hours after surgery

    The total dose of oxycodone within 48 hours after surgery

    48 hours after surgery

Secondary Outcomes (7)

  • The VSA-A Score

    From 1 day before surgery to the third day after surgery

  • The VSA-P Score

    From the first day to the third day after surgery

  • The incidence rate of analgesic related adverse reaction

    48 hours after surgery

  • The usage of extra analgesics after surgery

    48 hours after surgery

  • The kind and usage of anesthetics for anesthesia induction and maintenance

    During the surgery

  • +2 more secondary outcomes

Other Outcomes (2)

  • Changes of resting beta power of electroencephalography in the central brain areas by preoperative treatment

    1 hour before surgery

  • Changes of resting beta power of electroencephalography in the frontal midline brain areas by preoperative treatment

    1 hour before surgery

Study Arms (2)

Oxycodone with Perioperative Music Therapy

EXPERIMENTAL

Using perioperative music therapy plus oxycodone to manage the postoperative pain

Other: Perioperative Music Therapy

Oxycodone without Perioperative Music Therapy

NO INTERVENTION

Using oxycodone only to manage the postoperative pain

Interventions

Music therapist will play customized music in the perioperative period on the basis of oxycodone analgesia

Oxycodone with Perioperative Music Therapy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Enhanced CT or PET/CT indicate primary malignant pulmonary nodule;
  • The clinical stage belongs to cT1-4N0-2M0 before treatment or ycT1-4N0-2M0 after neoadjuvant treatment (AJCC/TNM 8th Edition);
  • Suitable for video-assisted thoracoscopic surgery after evaluated by thoracic surgeon;
  • FEV1 \> 1.5L and DLCO \> 60% pred;
  • Hearing loss lesser than 35 decibels (dB) in the better hearing ear;
  • Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 2;
  • American Society of Anesthesiologists Score of 1 or 2;
  • Confirmed eligibility for R0 resection for curative intent by thoracic surgeon assessment;
  • Adequate cardiopulmonary function, confirmed to meet the requirement for surgical resection for curative intent;
  • Able to provide written informed consent and able to understand and agree to comply with study requirements and evaluation forms;
  • Life expectancy greater than 12 months

You may not qualify if:

  • Enhanced CT or PET/CT indicate metastatic malignant pulmonary nodule;
  • Hearing loss greater than 35 decibels (dB) in the better hearing ear;
  • Active autoimmune disease or history of autoimmune disease that may recur; Note: well-controlled type 1 diabetes is allowed; hypothyroidism (controlled with thyroid hormone replacement only); well-controlled celiac disease; skin disease not requiring systemic treatment (eg, vitiligo, psoriasis, alopecia); any other condition that is not expected to recur in the absence of an external trigger.
  • History of interstitial lung disease, pneumonitis or uncontrolled systemic diseases, including diabetes, hypertension, pulmonary fibrosis, acute lung disease;
  • Serious infection occurred before grouping, including but not limited to hospitalization due to infectious complications, bacteremia or severe pneumonia; severe chronic or active infection (including pulmonary tuberculosis infection, etc.) requiring systemic (oral or intravenous) antibiotics within 14 days before grouping;
  • Simultaneous participation in another therapeutic clinical study;
  • Pregnant or lactating women, or male and female patients planning to have children during the study;
  • Other conditions that the investigators consider inappropriate for participation in this trial, such as poor compliance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sun Yat-sen University Cancer Center

Guangzhou, Guangdong, 510000, China

Location

Related Publications (2)

  • Palmer JB, Lane D, Mayo D, Schluchter M, Leeming R. Effects of Music Therapy on Anesthesia Requirements and Anxiety in Women Undergoing Ambulatory Breast Surgery for Cancer Diagnosis and Treatment: A Randomized Controlled Trial. J Clin Oncol. 2015 Oct 1;33(28):3162-8. doi: 10.1200/JCO.2014.59.6049. Epub 2015 Aug 17.

    PMID: 26282640BACKGROUND
  • Zhou W, Ye C, Wang H, Mao Y, Zhang W, Liu A, Yang CL, Li T, Hayashi L, Zhao W, Chen L, Liu Y, Tao W, Zhang Z. Sound induces analgesia through corticothalamic circuits. Science. 2022 Jul 8;377(6602):198-204. doi: 10.1126/science.abn4663. Epub 2022 Jul 7.

MeSH Terms

Conditions

AgnosiaLung NeoplasmsAnxiety Disorders

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesMental Disorders

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients will be randomly assigned into two groups, the experimental group will receive music therapy and oxycodone for the pain management after thoracic surgery. The control group will only use oxycodone to relief the pain.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

July 31, 2023

First Posted

August 8, 2023

Study Start

August 1, 2023

Primary Completion

January 20, 2024

Study Completion

April 20, 2024

Last Updated

July 17, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations